Wed, Aug 19 01:03 PM

Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term

Seeking Alpha•Wed, Aug 19, 2026, 11:15 AM•2 min read

Developing story — details emerging. Check the source link for the latest updates.

Source: [Seeking Alpha](https://seekingalpha.com/article/4937618-abbott-laboratories-reasonably-valued-after-surge-but-still-an-attractive-buy-long-term?source=feed_all_articles)

📰 Read Full Story

This is an aggregated headline summary. For the complete report, visit the original publisher.

Continue Reading at Seeking Alpha ↗

#finance #abbott #laboratories #reasonably #valued #surge #attractive #buy #long

More Headlines

FinanceCNBC• 4m ago

Treasury announces upscaled buyback operation for longer-term debt, sending yields lower

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 5m ago

Pagaya Technologies: A Fast-Growing Industry Disruptor Trading At A P/E Of 6.6x

Developing story — details emerging. Check the source link for the latest updates.

FinanceCNBC• 6m ago

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%

The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

FinanceSeeking Alpha• 7m ago

Cardinal Health: Precision Medicine Drives A Sustained Revenue Growth Path

Developing story — details emerging. Check the source link for the latest updates.

FinanceSeeking Alpha• 10m ago

3-Day Reprieve For Canada From U.S. Tariffs

Developing story — details emerging. Check the source link for the latest updates.

FinanceInvesting.com• 12m ago

Earnings call transcript: Oxford Nanopore jumps 16% after H1 2026 update

Developing story — details emerging. Check the source link for the latest updates.